Clinical trials: Cerebral Amyloid Angiopathy
Amyloid Angiopathy
Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid
The cerebral amyloïd angiopathy ( AAC) is a disease characterized by deposits of beta-amyloid peptids in the walls of the arteries of young and average calibre of the brain and the leptomeninx.
- Trial name
- NCT03262246
- Testing
- medical report consultation
- Where
- France
- Volunteers
- 126 people
- Sponsor
- Fondation Hôpital Saint-Joseph
Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
In this three-year proposal, we will explore the MRI-visible EPVS in CAA and investigate its pathophysiology using animal models.
- Trial name
- CAA (NCT04604587)
- Testing
- 1. amyloid PET；2. T807 PET
- Where
- Taiwan
- Volunteers
- 120 people
- Sponsor
- National Taiwan University Hospital